Real world rates of genetic referrals and germline testing in patients with prostate adenocarcinoma at an academic cancer center in southern New Jersey. This is an ASCO Meeting Abstract from the 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results